title: Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations.
abstract: Tuberculosis (TB) is the major cause of human mortality from a curable infectious disease, attacking mainly in developing countries. Among targets identified in Mycobacterium tuberculosis genome, enzymes of the shikimate pathway deserve special attention, since they are essential to the survival of the microorganism and absent in mammals. The object of our study is shikimate kinase (SK), the fifth enzyme of this pathway. We applied virtual screening methods in order to identify new potential inhibitors for this enzyme. In this work we employed MOLDOCK program in all molecular docking simulations. Accuracy of enzyme-ligand docking was validated on a set of 12 SK-ligand complexes for which crystallographic structures were available, generating root-mean square deviations below 2.0 Å. Application of this protocol against a commercially available database allowed identification of new molecules with potential to become drugs against TB. Besides, we have identified the binding cavity residues that are essential to intermolecular interactions of this enzyme.
authors: Faculdade de Biociências, Instituto Nacional de Ciência e Tecnologia em Tuberculose (INCT-TB), Laboratório de Bioquímica Estrutural (LaBioQuest), Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Av. Ipiranga 6681, Porto Alegre, RS 90619-900, Brazil.
authors: Carolina Pasa
authors: CP
authors: Vianna
authors: Walter F
authors: WF
authors: de Azevedo
references: Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W738-44
references: 16845110
references: J Med Chem. 2004 Mar 25;47(7):1739-49
references: 15027865
references: J Mol Biol. 1998 May 22;278(5):983-97
references: 9600856
references: Proteins. 2004 May 1;55(2):288-304
references: 15048822
references: Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Jan 1;63(Pt 1):1-6
references: 17183161
references: Biochem Biophys Res Commun. 2002 Apr 26;293(1):566-71
references: 12054639
references: J Med Chem. 2006 Nov 16;49(23):6789-801
references: 17154509
references: Annu Rev Biophys Biomol Struct. 2003;32:335-73
references: 12574069
references: J Mol Biol. 2002 Jun 7;319(3):779-89
references: 12054870
references: Crit Rev Biochem Mol Biol. 1990;25(5):307-84
references: 2279393
references: Chem Biol Drug Des. 2010 Sep 1;76(3):277-84
references: 20626408
references: Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
references: 11259830
references: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 2):2310-9
references: 15583379
references: Curr Drug Targets. 2010 Mar;11(3):261-3
references: 20214598
references: Mem Inst Oswaldo Cruz. 2005 Oct;100(6):475-506
references: 16302058
references: Curr Drug Targets. 2010 Mar;11(3):327-34
references: 20210757
references: J Comput Chem. 2004 Apr 30;25(6):843-57
references: 15011256
references: Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2735-40
references: 8610110
references: J Chem Inf Model. 2005 Jan-Feb;45(1):177-82
references: 15667143
references: Nat Struct Biol. 1997 Oct;4(10):796-801
references: 9334743
references: J Chem Inf Model. 2010 Mar 22;50(3):415-21
references: 20158272
references: Anal Chem. 2010 May 1;82(9):3616-21
references: 20394394
references: Curr Drug Targets. 2008 Dec;9(12):1092-9
references: 19128220
references: Science. 2004 Mar 19;303(5665):1800-5
references: 15031492
references: Microbiology (Reading). 2002 Oct;148(Pt 10):3069-3077
references: 12368440
references: Protein Eng. 1995 Feb;8(2):127-34
references: 7630882
references: Antimicrob Agents Chemother. 1994 Feb;38(2):403-6
references: 8192477
references: Eur J Biochem. 1997 Jan 15;243(1-2):518-26
references: 9030780
references: Bioorg Med Chem Lett. 2008 Jun 1;18(11):3152-7
references: 18486472
references: Structure. 1995 May 15;3(5):483-90
references: 7663945
references: J Med Chem. 2006 Jun 1;49(11):3315-21
references: 16722650